1. Market access of biosimilars: not only a cost issue;Simoens;Oncologie,2011
2. GaBI Online Generics and Biosimilars Initiative. Generics grab 80% share of US market and fill 78% of prescriptions [www.gabionline.net]. Mol, Belgium: Pro Pharma Communications International; [cited 2012 Mar 23] 2012a www.gabionline.net/Reports/Generics-grab-80-share-of-US-marketand-fill-78-of-prescriptions
3. GaBI Online Generics and Biosimilars Initiative. Biosimilars approved in Europe [www.gabionline.net]. Mol, Belgium: Pro Pharma Communications International; [cited 2012 Mar 23] 2012b www.gabionline.net/Biosimilars/General/Biosimilars-approved-in-Europe
4. Statistical assessment of biosimilar products;Chow;Journal of Biopharmaceutical Statistics,2010